Product Code: ETC6192117 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Australia Sufentanil Market involves the supply and use of this potent opioid analgesic primarily in medical settings. Sufentanil is used for pain management during surgery and intensive care. The market is shaped by factors such as rising surgical procedures, growing geriatric population, and increased focus on pain management therapies. Regulatory controls and concerns over opioid misuse also impact market dynamics. Pharmaceutical companies are focusing on safe delivery systems and formulation innovations to meet clinical demands.
The Sufentanil market in Australia is characterized by increasing usage in anesthesia and pain management, especially in critical care and surgical settings. The trend toward opioid stewardship programs influences prescribing patterns, promoting careful usage to minimize dependency risks. There is ongoing research and interest in developing alternative delivery methods, such as transdermal and sublingual formulations, to improve patient comfort and compliance. Regulatory scrutiny and supply chain management remain key factors impacting market dynamics.
The Sufentanil market in Australia is challenged by regulatory scrutiny due to the opioid crisis, which limits prescribing practices and tightens distribution controls. There is also a growing demand for non-opioid pain management alternatives, reducing market potential. Supply chain complexities and pricing pressures from government reimbursement policies further constrain the market. Additionally, healthcare providers require extensive training to safely administer potent opioids like Sufentanil, which can affect usage rates.
The Sufentanil Market in Australia offers targeted investment opportunities within the pharmaceutical and healthcare segments, particularly in anesthesia and pain management. With an increasing prevalence of surgical procedures and chronic pain cases, demand for potent opioid analgesics like sufentanil is on the rise under strict regulatory frameworks. Investment prospects include pharmaceutical companies focusing on sufentanil production, novel delivery systems, and combination therapies with improved safety profiles.
The Sufentanil market is heavily regulated due to the drugs classification as a Schedule 8 controlled substance in Australia. The government enforces stringent regulations around prescribing, distribution, and storage to prevent misuse and diversion. The Therapeutic Goods Administrations approval and ongoing pharmacovigilance policies govern its market presence. Moreover, national opioid stewardship programs aimed at managing pain treatment and reducing addiction risks shape market dynamics.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Sufentanil Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Sufentanil Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Sufentanil Market - Industry Life Cycle |
3.4 Australia Sufentanil Market - Porter's Five Forces |
3.5 Australia Sufentanil Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Australia Sufentanil Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Australia Sufentanil Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Australia Sufentanil Market Revenues & Volume Share, By Doses, 2021 & 2031F |
3.9 Australia Sufentanil Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Australia Sufentanil Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Sufentanil Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Sufentanil Market Trends |
6 Australia Sufentanil Market, By Types |
6.1 Australia Sufentanil Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Australia Sufentanil Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Australia Sufentanil Market Revenues & Volume, By Opioid Analgesic, 2021- 2031F |
6.1.4 Australia Sufentanil Market Revenues & Volume, By Anaesthetic, 2021- 2031F |
6.2 Australia Sufentanil Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Sufentanil Market Revenues & Volume, By Intravenous Route, 2021- 2031F |
6.2.3 Australia Sufentanil Market Revenues & Volume, By Epidural Route, 2021- 2031F |
6.2.4 Australia Sufentanil Market Revenues & Volume, By Sublingual Route, 2021- 2031F |
6.3 Australia Sufentanil Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Australia Sufentanil Market Revenues & Volume, By Branded, 2021- 2031F |
6.3.3 Australia Sufentanil Market Revenues & Volume, By Generic, 2021- 2031F |
6.4 Australia Sufentanil Market, By Doses |
6.4.1 Overview and Analysis |
6.4.2 Australia Sufentanil Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.3 Australia Sufentanil Market Revenues & Volume, By Pediatrics, 2021- 2031F |
6.4.4 Australia Sufentanil Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5 Australia Sufentanil Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Australia Sufentanil Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Australia Sufentanil Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.4 Australia Sufentanil Market Revenues & Volume, By Other, 2021- 2031F |
6.6 Australia Sufentanil Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Sufentanil Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Australia Sufentanil Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Australia Sufentanil Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Australia Sufentanil Market Import-Export Trade Statistics |
7.1 Australia Sufentanil Market Export to Major Countries |
7.2 Australia Sufentanil Market Imports from Major Countries |
8 Australia Sufentanil Market Key Performance Indicators |
9 Australia Sufentanil Market - Opportunity Assessment |
9.1 Australia Sufentanil Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Australia Sufentanil Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Australia Sufentanil Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Australia Sufentanil Market Opportunity Assessment, By Doses, 2021 & 2031F |
9.5 Australia Sufentanil Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Australia Sufentanil Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Sufentanil Market - Competitive Landscape |
10.1 Australia Sufentanil Market Revenue Share, By Companies, 2024 |
10.2 Australia Sufentanil Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |